Cited by 152T-cell and Retrovirus StudiesInfectious Diseases and TuberculosisHIV Research and Treatment

Increased HTLV‐I proviral DNA in HTLV‐I–associated myelopathy: A quantitative polymerase chain reaction study

Kira, Jun‐ichi, Koyanagi, Yoshio, Yamada, Takeshi, Itoyama, Yasuto, Goto, Ikuo, Yamamoto, Naoki, Sasaki, Hiroyuki, Sakaki, Yoshiyuki·1991·Annals of Neurology

Abstract

Using the polymerase chain reaction, we quantitated the amount of human T‐lymphotropic virus type I (HTLV‐I) proviral DNA in peripheral blood mononuclear cells from 18 patients with HTLV‐I–associated myelopathy/tropical spastic paraparesis; 17 HTLV‐I carriers without HTLV‐I–associated myelopathy/tropical spastic paraparesis, with or without other autoimmune or inflammatory diseases; and 19 seronegative control subjects. The HTLV‐I proviral DNA was 10‐ to 100‐fold higher in the patients and in the HTLV‐I carriers without HAM/TSP who had autoimmune or inflammatory diseases than in the carriers without autoimmune or inflammatory diseases. The patients who had had onset of myelopathy at a younger age (15 to 39 years) had an extremely high level of HTLV‐I proviral DNA in the early phase, as compared with findings in those with a late onset of myelopathy (at 44 to 61 years). The large increase in HTLV‐I proviral DNA in peripheral blood mononuclear cells is presumably closely related to the development of autoimmune or inflammatory processes in HTLV‐I carriers, including HTLV‐I–associated myelopathy/tropical spastic paraparesis.

Integrity signals

Registry

Crossref · 10.1002/ana.410290214

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increased HTLV-1 PVL in PBMCs is a potent risk factor for disease progression.

    “There is strong evidence suggesting that increased HTLV-1 PVL in PBMCs is a potent risk factor for disease progression [216,271,272,273].”

    From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [271]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kira, J., Koyanagi, Y., Yamada, T., Itoyama, Y., Goto, I., Yamamoto, N., Sasaki, H., & Sakaki, Y.
Affiliations
  • Kyushu University (JP)
  • Yamaguchi University (JP)
Corresponding author
Kira, Jun‐ichi
Venue
Annals of Neurology
Publisher
Wiley
Published
1991-02
Volume
29
Issue
2
Pages
194-201
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2089048401
Cited by
152
References
41
Citations by year
2024: 6 · 2023: 2 · 2022: 2 · 2020: 1 · 2017: 1 · 2016: 1 · 2013: 3 · 2012: 4
FWCI
5.05
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Neurology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
  • Health Sciences › Medicine › Surgery › Infectious Diseases and Tuberculosis
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords
HTLV-1, proviral DNA, tropical spastic paraparesis, peripheral blood mononuclear cells, HTLV-1 carriers, autoimmune disease, inflammatory diseases, age of onset, viral load
MeSH terms
Adult, Age Factors, Aged, Aged, 80 and over, DNA, Viral, Female, Humans, Leukocytes, Mononuclear, Male, Middle Aged, Human T-lymphotropic virus 1, Paraparesis, Tropical Spastic, Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review